Investors
Press Releases
Press releases issued by Palatin are accessible below. These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships.
Found 304 Results
Palatin Announces $5 Million Registered Direct Offering
October 23, 2023
Palatin Announces Preliminary Quarter Ended September 30, 2023 Vyleesi® Product Revenue Results
October 19, 2023
Palatin Presents Data at the United European Gastroenterology Week 2023 Conference On PL8177 Ulcerative Colitis Treatment
October 16, 2023
Palatin Receives Notice of Non-Compliance from NYSE American
October 13, 2023
Palatin Reports Fourth Quarter and Fiscal Year Ended 2023 Financial Results and Provides Corporate Update
September 28, 2023
Palatin to Report Fourth Quarter and Fiscal Year End 2023 Results; Teleconference and Webcast to be held on September 28, 2023
September 22, 2023
Palatin to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 7, 2023